Cite
HARVARD Citation
Yamashita, T. et al. (n.d.). 1955 Primary systemic therapy by dual HER2 blockage with lapatinib (La) + trastuzumab (T) for Japanese patients (pts) with HER2+ breast cancer (BC): Association of La toxicity and dose with treatment efficacy. European journal of cancer. pp. S317-S318. [Online].